|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/28 | |||
| A61K 31/444 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61K 47/38 |
| (11) | Number of the document | 2627319 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11779278.8 |
| Date of filing the European patent application | 2011-10-14 | |
| (97) | Date of publication of the European application | 2013-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/056275 |
| Date | 2011-10-14 |
| (87) | Number | WO 2012/051488 |
| Date | 2012-04-19 |
| (30) | Number | Date | Country code |
| 393103 P | 2010-10-14 | US |
| (72) |
WEN, Hong, US
KUMARAPERUMAL, Natrajan, US
NAUSE, Richard, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR |
| PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR |